Pathway,Total,Expected,Hits,P.Value,FDR
Chemokine signaling pathway,190,2.92,36,2.58e-30,8.19e-28
Rap1 signaling pathway,206,3.17,35,9.99e-28,1.59e-25
Morphine addiction,91,1.4,26,7.52e-27,7.98e-25
Phospholipase D signaling pathway,148,2.28,30,4.26e-26,3.39e-24
Endocrine resistance,98,1.51,26,6.51e-26,4.14e-24
Platelet activation,124,1.91,28,9.4e-26,4.98e-24
Proteoglycans in cancer,201,3.09,33,1.33e-25,6.06e-24
Pathways in cancer,530,8.15,46,9.12e-24,3.62e-22
Focal adhesion,199,3.06,31,2.61e-23,9.23e-22
Ras signaling pathway,232,3.57,32,2.24e-22,7.12e-21
Estrogen signaling pathway,138,2.12,26,9.24e-22,2.67e-20
Inflammatory mediator regulation of TRP channels,100,1.54,23,2.09e-21,5.53e-20
Dilated cardiomyopathy,91,1.4,22,5.13e-21,1.26e-19
GnRH signaling pathway,93,1.43,22,8.63e-21,1.96e-19
Longevity regulating pathway - multiple species,62,0.954,19,2.01e-20,4.26e-19
Cholinergic synapse,112,1.72,23,3.36e-20,6.68e-19
Progesterone-mediated oocyte maturation,99,1.52,22,3.79e-20,7.09e-19
Gap junction,88,1.35,21,5.83e-20,1.03e-18
Regulation of lipolysis in adipocytes,55,0.846,17,1.96e-18,3.28e-17
Longevity regulating pathway,89,1.37,19,3.8e-17,6.04e-16
PI3K-Akt signaling pathway,354,5.44,32,9.28e-17,1.41e-15
cAMP signaling pathway,212,3.26,25,7.47e-16,1.05e-14
GABAergic synapse,89,1.37,18,7.62e-16,1.05e-14
Apelin signaling pathway,137,2.11,21,9.26e-16,1.23e-14
EGFR tyrosine kinase inhibitor resistance,79,1.22,17,1.69e-15,2.15e-14
Leukocyte transendothelial migration,112,1.72,19,3.53e-15,4.32e-14
Ovarian steroidogenesis,49,0.754,14,8.17e-15,9.63e-14
Neurotrophin signaling pathway,119,1.83,19,1.13e-14,1.29e-13
Circadian entrainment,97,1.49,17,6.38e-14,7e-13
Regulation of actin cytoskeleton,214,3.29,23,9.47e-14,1e-12
AGE-RAGE signaling pathway in diabetic complications,100,1.54,17,1.08e-13,1.1e-12
Oxytocin signaling pathway,153,2.35,20,1.11e-13,1.1e-12
Melanogenesis,101,1.55,17,1.28e-13,1.24e-12
Bacterial invasion of epithelial cells,74,1.14,15,2.22e-13,2.07e-12
Retrograde endocannabinoid signaling,148,2.28,19,6.77e-13,6.15e-12
Glutamatergic synapse,114,1.75,17,1.01e-12,8.94e-12
Fc epsilon RI signaling pathway,68,1.05,14,1.17e-12,1.01e-11
ErbB signaling pathway,85,1.31,15,1.9e-12,1.59e-11
Gastric acid secretion,75,1.15,14,4.86e-12,3.87e-11
Glioma,75,1.15,14,4.86e-12,3.87e-11
Adrenergic signaling in cardiomyocytes,145,2.23,18,5.19e-12,4.02e-11
Purine metabolism,130,2,17,9.06e-12,6.86e-11
Vascular smooth muscle contraction,132,2.03,17,1.17e-11,8.62e-11
Aldosterone synthesis and secretion,98,1.51,15,1.63e-11,1.18e-10
Insulin signaling pathway,137,2.11,17,2.14e-11,1.52e-10
Renal cell carcinoma,69,1.06,13,2.6e-11,1.8e-10
Insulin secretion,86,1.32,14,3.42e-11,2.31e-10
VEGF signaling pathway,59,0.907,12,6.09e-11,4.03e-10
Thyroid hormone synthesis,74,1.14,13,6.6e-11,4.28e-10
Chronic myeloid leukemia,76,1.17,13,9.38e-11,5.97e-10
Natural killer cell mediated cytotoxicity,131,2.01,16,1.12e-10,6.96e-10
Axon guidance,181,2.78,18,2.24e-10,1.37e-09
Non-small cell lung cancer,66,1.02,12,2.45e-10,1.47e-09
ECM-receptor interaction,82,1.26,13,2.54e-10,1.49e-09
Kaposi's sarcoma-associated herpesvirus infection,186,2.86,18,3.51e-10,2.03e-09
Prolactin signaling pathway,70,1.08,12,5.02e-10,2.85e-09
MAPK signaling pathway,295,4.54,22,5.13e-10,2.86e-09
Oocyte meiosis,125,1.92,15,5.74e-10,3.15e-09
Bile secretion,72,1.11,12,7.07e-10,3.77e-09
HTLV-I infection,219,3.37,19,7.11e-10,3.77e-09
Salivary secretion,90,1.38,13,8.43e-10,4.4e-09
Fc gamma R-mediated phagocytosis,91,1.4,13,9.71e-10,4.98e-09
cGMP-PKG signaling pathway,166,2.55,16,3.88e-09,1.96e-08
Viral carcinogenesis,201,3.09,17,9.02e-09,4.48e-08
FoxO signaling pathway,132,2.03,14,1.14e-08,5.59e-08
Pancreatic secretion,98,1.51,12,2.67e-08,1.29e-07
HIF-1 signaling pathway,100,1.54,12,3.37e-08,1.6e-07
B cell receptor signaling pathway,71,1.09,10,1.06e-07,4.96e-07
Calcium signaling pathway,188,2.89,15,1.58e-07,7.26e-07
Thyroid hormone signaling pathway,116,1.78,12,1.79e-07,8.14e-07
Amoebiasis,96,1.48,11,2.1e-07,9.4e-07
Prostate cancer,97,1.49,11,2.34e-07,1.03e-06
Sphingolipid signaling pathway,119,1.83,12,2.38e-07,1.04e-06
Choline metabolism in cancer,99,1.52,11,2.88e-07,1.24e-06
T cell receptor signaling pathway,101,1.55,11,3.54e-07,1.5e-06
Osteoclast differentiation,128,1.97,12,5.3e-07,2.22e-06
Shigellosis,65,1,9,5.51e-07,2.28e-06
Hypertrophic cardiomyopathy (HCM),85,1.31,10,6e-07,2.45e-06
Epithelial cell signaling in Helicobacter pylori infection,68,1.05,9,8.18e-07,3.29e-06
Renin secretion,69,1.06,9,9.28e-07,3.69e-06
Hepatitis B,163,2.51,13,1.13e-06,4.43e-06
Signaling pathways regulating pluripotency of stem cells,139,2.14,12,1.29e-06,5e-06
Serotonergic synapse,115,1.77,11,1.32e-06,5.07e-06
Melanoma,72,1.11,9,1.34e-06,5.08e-06
Endometrial cancer,58,0.892,8,2.49e-06,9.33e-06
Chagas disease (American trypanosomiasis),103,1.58,10,3.59e-06,1.33e-05
Dopaminergic synapse,131,2.01,11,4.8e-06,1.76e-05
Colorectal cancer,86,1.32,9,6.05e-06,2.19e-05
Hedgehog signaling pathway,47,0.723,7,6.45e-06,2.3e-05
Acute myeloid leukemia,66,1.02,8,6.75e-06,2.38e-05
Long-term potentiation,67,1.03,8,7.56e-06,2.64e-05
Vibrio cholerae infection,50,0.769,7,9.85e-06,3.41e-05
MicroRNAs in cancer,299,4.6,16,1.21e-05,4.15e-05
Arrhythmogenic right ventricular cardiomyopathy (ARVC),72,1.11,8,1.3e-05,4.4e-05
Breast cancer,147,2.26,11,1.46e-05,4.87e-05
Alcoholism,180,2.77,12,1.89e-05,6.27e-05
Autophagy - animal,128,1.97,10,2.5e-05,8.19e-05
Long-term depression,60,0.923,7,3.36e-05,0.000109
Jak-STAT signaling pathway,162,2.49,11,3.62e-05,0.000116
Vasopressin-regulated water reabsorption,44,0.677,6,5.11e-05,0.000162
Central carbon metabolism in cancer,65,1,7,5.68e-05,0.000179
Endocrine and other factor-regulated calcium reabsorption,48,0.738,6,8.45e-05,0.000263
Cocaine addiction,49,0.754,6,9.51e-05,0.000294
Hepatitis C,155,2.38,10,0.000128,0.00039
Pancreatic cancer,75,1.15,7,0.000143,0.000432
Pertussis,76,1.17,7,0.000155,0.000465
Complement and coagulation cascades,79,1.22,7,0.000198,0.000588
Aldosterone-regulated sodium reabsorption,37,0.569,5,0.000233,0.000685
Insulin resistance,108,1.66,8,0.000242,0.000705
Taste transduction,83,1.28,7,0.00027,0.000779
Fluid shear stress and atherosclerosis,139,2.14,9,0.000273,0.000782
Toxoplasmosis,113,1.74,8,0.00033,0.000936
Bladder cancer,41,0.631,5,0.000381,0.00107
Small cell lung cancer,93,1.43,7,0.000542,0.00151
mTOR signaling pathway,153,2.35,9,0.000554,0.00153
Type II diabetes mellitus,46,0.708,5,0.000655,0.0018
Inositol phosphate metabolism,74,1.14,6,0.000922,0.00248
Leishmaniasis,74,1.14,6,0.000922,0.00248
Epstein-Barr virus infection,201,3.09,10,0.00102,0.00272
Cellular senescence,160,2.46,8,0.00316,0.00837
